Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Shire PLC    SHP   JE00B2QKY057


Delayed Quote. Delayed  - 02/24 11:22:07 am
4857.32 GBp   -1.43%
11:08a SHIRE : Director/PDMR Shareholding
02/23 SHIRE : Launches “Rare Count” ...
02/23 SHIRE : New England Journal of Medicine ...
News SummaryMost relevantAll newsSector newsTweets 

Shire : Files 8K - Other Events

share with twitter share with LinkedIn share with facebook
share via e-mail
02/17/2017 | 07:24pm CET

Shire PLC (SHPG) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on February 17, 2017.

Shire plc has issued the press release attached hereto as Exhibit 99.1 which is incorporated by reference herein.

The full text of this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/936402/000095010317001531/dp73113_8k.htm

Any exhibits and associated documents for this SEC filing can be retrieved at: http://www.sec.gov/Archives/edgar/data/936402/000095010317001531/0000950103-17-001531-index.htm

Public companies must file a Form 8-K, or current report, with the SEC generally within four days of any event that could materially affect a company's financial position or the value of its shares.

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on SHIRE PLC
11:08a SHIRE : Director/PDMR Shareholding
02/23 SHIRE : Launches “Rare Count” ...
02/23 SHIRE : New England Journal of Medicine ...
02/21 Icahn buys Bristol-Myers shares, adding to activist pressure
02/21DJSHIRE : Files 8K - Other Events
02/21 SHIRE PLC : Financial Statements and Exhibits (form 8-K)
02/21 SHIRE : *hsbc raises shire price target to 4,550 (4,500) pence - 'hold'
02/20 British FTSE 100 decreases 0.34 pct on Thursday
02/20 SHIRE : Director/PDMR Shareholding
02/20 SHIRE PLC (NASDAQ : SHPG) Files An 8-K Other Events
More news
Sector news : Pharmaceuticals - NEC
12:59a Exclusive - Trump says Republican border tax could boost U.S. jobs
02/23DJPFIZER : Files 8K - Changes Executive Management
02/23DJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
02/23DJPURETECH HEALTH : Appoints Atul Pande as Chief Medical Officer
02/23DJBAYER : Financing Plan Will Raise Equity First Then Bonds -- WSJ
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
02/23 Early-stage study shows encouraging results for Shire's candidate for heredit..
02/23 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2016 Update
02/21 PROTALIX BIOTHERAPEUTICS : New Institutional Ownership Swells Ahead Of Major Cat..
02/20 Tracking John Paulson's Paulson & Company Portfolio - Q4 2016 Update
02/20 Why Shire's 2017 Guidance Is Encouraging And Should Reassure Investors
Financials ($)
Sales 2017 15 252 M
EBIT 2017 5 882 M
Net income 2017 3 028 M
Debt 2017 18 111 M
Yield 2017 0,59%
P/E ratio 2017 16,37
P/E ratio 2018 12,56
EV / Sales 2017 4,83x
EV / Sales 2018 4,21x
Capitalization 55 496 M
More Financials
Duration : Period :
Shire PLC Technical Analysis Chart | SHP | JE00B2QKY057 | 4-Traders
Full-screen chart
Technical analysis trends SHIRE PLC
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 74,0 $
Spread / Average Target 20%
Consensus details
EPS Revisions
More Estimates Revisions
Flemming Ornskov Chief Executive Officer & Executive Director
Susan Saltzbart Kilsby Non-Executive Chairman
Jeffrey Poulton Chief Financial Officer & Executive Director
Philip J. Vickers Global Head-Research & Development
David R. Ginsburg Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
SHIRE PLC3.65%55 496
JOHNSON & JOHNSON3.74%331 089
ROCHE HOLDING LTD.5.98%209 906
PFIZER INC.3.42%206 688
NOVARTIS AG3.51%201 806
MERCK & CO., INC.10.91%181 558
More Results